GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice
出版年份 2017 全文链接
标题
GUB06-046, a novel secretin/glucagon-like peptide 1 co-agonist, decreases food intake, improves glycemic control, and preserves beta cell mass in diabetic mice
作者
关键词
-
出版物
JOURNAL OF PEPTIDE SCIENCE
Volume 23, Issue 12, Pages 845-854
出版商
Wiley
发表日期
2017-10-23
DOI
10.1002/psc.3048
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Liraglutide: A Review of Its Use in the Management of Obesity
- (2015) Lesley J. Scott DRUGS
- Effects of secretin on neuronal activity and feeding behavior in central amygdala of rats
- (2015) Ya-Yan Pang et al. PEPTIDES
- A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents
- (2015) Louise S. Dalbøge et al. PLoS One
- Effects of PYY3–36 and GLP-1 on energy intake, energy expenditure, and appetite in overweight men
- (2014) Julie Berg Schmidt et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- The potential risks of pancreatitis and pancreatic cancer with GLP-1-based therapies are far outweighed by the proven and potential (cardiovascular) benefits
- (2014) R. E. J. Ryder DIABETIC MEDICINE
- Secretin receptor-knockout mice are resistant to high-fat diet-induced obesity and exhibit impaired intestinal lipid absorption
- (2014) Revathi Sekar et al. FASEB JOURNAL
- Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the Global Burden of Disease Study 2013
- (2014) Marie Ng et al. LANCET
- A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents
- (2014) Brian Finan et al. NATURE MEDICINE
- A Meta-Analysis of Short-Term Outcomes of Patients with Type 2 Diabetes Mellitus and BMI ≤35 kg/m2 Undergoing Roux-en-Y Gastric Bypass
- (2014) Wen-Sheng Rao et al. WORLD JOURNAL OF SURGERY
- Update for BayesApp: a web site for analysis of small-angle scattering data
- (2014) Steen Hansen JOURNAL OF APPLIED CRYSTALLOGRAPHY
- A PEGylated analog of the gut hormone oxyntomodulin with long-lasting antihyperglycemic, insulinotropic and anorexigenic activity
- (2013) Elisabetta Bianchi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
- (2013) Martin Lorenz et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Critical Analysis of the Clinical Use of Incretin-Based Therapies: Are the GLP-1 therapies safe?
- (2013) P. C. Butler et al. DIABETES CARE
- A Novel Glucagon-like Peptide-1 (GLP-1)/Glucagon Hybrid Peptide with Triple-acting Agonist Activity at Glucose-dependent Insulinotropic Polypeptide, GLP-1, and Glucagon Receptors and Therapeutic Potential in High Fat-fed Mice
- (2013) Victor A. Gault et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Hypertrophy Dependent Doubling of L-Cells in Roux-en-Y Gastric Bypass Operated Rats
- (2013) Carl Frederik Hansen et al. PLoS One
- Characterisation of Age-Dependent Beta Cell Dynamics in the Male db/db Mice
- (2013) Louise S. Dalbøge et al. PLoS One
- Unimolecular Dual Incretins Maximize Metabolic Benefits in Rodents, Monkeys, and Humans
- (2013) B. Finan et al. Science Translational Medicine
- The effects of 13 wk of liraglutide treatment on endocrine and exocrine pancreas in male and female ZDF rats: a quantitative and qualitative analysis revealing no evidence of drug-induced pancreatitis
- (2012) Niels Vrang et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Optimization of co-agonism at GLP-1 and glucagon receptors to safely maximize weight reduction in DIO-rodents
- (2012) Jonathan W. Day et al. BIOPOLYMERS
- Outstanding Scientific Achievement Award Lecture 2011: Defeating Diabesity: The Case for Personalized Combinatorial Therapies
- (2012) M. H. Tschop et al. DIABETES
- Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12DMouse Model
- (2012) Belinda Gier et al. DIABETES
- BayesApp: a web site for indirect transformation of small-angle scattering data
- (2012) Steen Hansen JOURNAL OF APPLIED CRYSTALLOGRAPHY
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- Importance of Each Residue within Secretin for Receptor Binding and Biological Activity
- (2011) Maoqing Dong et al. BIOCHEMISTRY
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- Health and economic burden of the projected obesity trends in the USA and the UK
- (2011) Y Claire Wang et al. LANCET
- Discovery and characterization of taspoglutide, a novel analogue of human glucagon-like peptide-1, engineered for sustained therapeutic activity in type 2 diabetes
- (2010) J. Z. Dong et al. DIABETES OBESITY & METABOLISM
- Taspoglutide, an Analog of Human Glucagon-Like Peptide-1 with Enhanced Stability andin VivoPotency
- (2010) Elena Sebokova et al. ENDOCRINOLOGY
- Tesofensine, a Novel Triple Monoamine Reuptake Inhibitor, Induces Appetite Suppression by Indirect Stimulation of α1 Adrenoceptor and Dopamine D1 Receptor Pathways in the Diet-Induced Obese Rat
- (2010) Anne Marie D Axel et al. NEUROPSYCHOPHARMACOLOGY
- Central and Peripheral Administration of Secretin Inhibits Food Intake in Mice through the Activation of the Melanocortin System
- (2010) Carrie Yuen Yee Cheng et al. NEUROPSYCHOPHARMACOLOGY
- Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
- (2009) Henry Buchwald et al. AMERICAN JOURNAL OF MEDICINE
- Improvement in Glucose Metabolism After Bariatric Surgery: Comparison of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy
- (2009) Ralph Peterli et al. ANNALS OF SURGERY
- Glucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
- (2009) A. Pocai et al. DIABETES
- A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
- (2009) Jonathan W Day et al. Nature Chemical Biology
- Effect of Weight Loss by Gastric Bypass SurgeryVersusHypocaloric Diet on Glucose and Incretin Levels in Patients with Type 2 Diabetes
- (2008) Blandine Laferrère et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started